Understand the finished preparation
FDA describes compounding as combining, mixing or altering ingredients to create medication tailored to a patient’s needs. The agency also makes clear that compounded drugs are not FDA-approved and do not receive its premarket review for safety, effectiveness and quality.[source]
That distinction concerns the finished preparation. It should not be blurred by a familiar active ingredient, a prescription requirement or a provider’s statement that a pharmacy is licensed.
What personalization can contribute
A clinician may select a combination or formulation for a particular concern. The useful question is why that choice fits the person, not whether the word personalized sounds more advanced than a standard medicine.
Ask for the final ingredients, concentrations and directions. A product family may include several different recipes, so the website’s ingredient list and the individual prescription can legitimately differ.
Keep research attached to what was studied
Evidence for tretinoin or another ingredient can inform a treatment conversation. It does not show that every base, companion active and concentration has been studied as a finished combination. Claims about the whole product need evidence at the appropriate level.
This publication therefore distinguishes provider descriptions from dermatology guidance and regulatory context. We do not claim clinical testing of a custom cream or infer an outcome from its list of actives.
Ask who prepares and explains it
Confirm the dispensing pharmacy and a way to contact a pharmacist. Ask about storage, the labeled beyond-use information and what to do if the product looks different or the instructions are unclear.
The prescription and label should be consistent. If they appear to conflict, ask the prescriber or pharmacy to resolve the issue. A review cannot safely reconstruct a personalized formula or supply directions from another product.
Use the category without overreading it
Compounded does not mean a product is automatically the most tailored or best choice for every concern. Nor does the absence of FDA approval erase all research on its individual ingredients. Both overclaims lose the distinction that matters.
Compare the actual preparation, rationale and care arrangement with reasonable alternatives. Our consultation checklist turns those issues into concrete questions rather than a label-based ranking.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations